Lista de obras - Giuseppe Meco - Dominio Público Uruguay

A case-control study on Alzheimer's disease and exposure to anesthesia

artículo científico publicado en 2002

A cross-sectional multicenter study of cognitive and behavioural features in multiple system atrophy patients of the parkinsonian and cerebellar type

artículo científico publicado en 2013

A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease

scientific article published in The Lancet

A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease.

artículo científico publicado en 2005

A non-comparative assessment of tolerability and efficacy of duloxetine in the treatment of depressed patients with Parkinson's disease

artículo científico publicado en 2012

A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease

artículo científico publicado en 1999

ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease

artículo científico publicado en 2007

An appraisal of the problem of dementia in Parkinson's disease.

artículo científico publicado en 1984

Antidepressant use in treatment of psychosis with comorbid depression in Parkinson's disease

artículo científico publicado en 2006

Apolipoprotein E4 is probably responsible for the chromosome 19 linkage peak for Parkinson's disease

article

Aripiprazole in L-dopa-induced dyskinesias: a one-year open-label pilot study.

artículo científico publicado en 2009

Association between early-onset Parkinson's disease and mutations in the parkin gene

artículo científico publicado en 2000

Attentional functions in multiple system atrophy and Parkinson's disease

artículo científico publicado en 1996

Autosomal recessive early onset parkinsonism is linked to three loci: PARK2, PARK6, and PARK7

artículo científico publicado en 2002

Belly dance syndrome due to spinal myoclonus

Biological effects of the PINK1 c.1366C>T mutation: implications in Parkinson disease pathogenesis.

artículo científico publicado en 2007

Bladder symptoms assessed with overactive bladder questionnaire in Parkinson's disease

artículo científico publicado en 2010

Buspirone in levodopa-induced dyskinesias

artículo científico publicado en 1994

Chromosome 6-linked autosomal recessive early-onset Parkinsonism: linkage in European and Algerian families, extension of the clinical spectrum, and evidence of a small homozygous deletion in one family. The French Parkinson's Disease Genetics Study

artículo científico publicado en 1998

Clinical subtypes in Parkinson's disease: the impact of MAPT haplotypes

artículo científico publicado en 2013

Cognitive improvement during Tolcapone treatment in Parkinson's disease.

artículo científico publicado en 1997

Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease

artículo científico publicado en 2006

DAT gene polymorphisms (rs28363170, rs393795) and levodopa-induced dyskinesias in Parkinson's disease

article

Donepezil in the treatment of hallucinations and delusions in Parkinson's disease

artículo científico publicado en 2002

Donepezil in the treatment of progressive supranuclear palsy

artículo científico publicado en 2001

Early-onset parkinsonism associated with PINK1 mutations: frequency, genotypes, and phenotypes

artículo científico publicado en 2005

Epidemiology of progressive supranuclear palsy. ESGAP Consortium. European Study Group on Atypical Parkinsonisms

artículo científico publicado en 2001

Estimate of parkinsonism prevalence through drug prescription histories in the Province of Rome, Italy.

artículo científico publicado en 1995

Evaluation of risk of Parkinson's disease in a cohort of licensed pesticide users.

artículo científico publicado en 2002

Excessive daytime sleepiness in de novo and treated Parkinson's disease

artículo científico publicado en 2002

Excessive daytime sleepiness in multiple system atrophy (SLEEMSA study).

artículo científico publicado en 2011

Excessive daytime somnolence in Parkinson's disease. Follow-up after 1 year of treatment

artículo científico publicado en 2003

Frontal assessment battery scores and non-motor symptoms in parkinsonian disorders

artículo científico publicado en 2011

Frontal lobe dysfunction in essential tremor: a preliminary study

artículo científico publicado en 2001

GIGYF2 mutations are not a frequent cause of familial Parkinson's disease

artículo científico publicado en 2009

Genome-wide scan linkage analysis for Parkinson's disease: the European genetic study of Parkinson's disease

artículo científico publicado en 2004

Hallucinations in Parkinson disease: neuropsychological study.

artículo científico publicado en 1990

Health-related quality of life in multiple system atrophy

artículo científico publicado en 2006

Hedonistic homeostatic dysregulation in Parkinson’s disease: a short screening questionnaire ⬇️

artículo científico publicado el 1 de octubre de 2003

High prevalence of extrapyramidal signs and symptoms in a group of Italian dental technicians

artículo científico publicado en 2007

How much phenotypic variation can be attributed to parkin genotype?

artículo científico publicado en 2003

Hypothalamo-pituitary function and dopamine dependence in untreated parkinsonian patients

artículo científico publicado en 1991

Increased expression of dopamine receptors on lymphocytes in Parkinson's disease

artículo científico publicado en 1999

LRP10 genetic variants in familial Parkinson's disease and dementia with Lewy bodies: a genome-wide linkage and sequencing study

scholarly article by Marialuisa Quadri et al published July 2018 in Lancet Neurology

Levetiracetam in L-dopa-induced dyskinesia

artículo científico publicado en 2005

Mirtazapine in L-dopa-induced dyskinesias

artículo científico publicado en 2003

Mortality in a population-based cohort of patients treated with antiparkinsonian drugs.

artículo científico publicado en 1998

Mortality rates for Parkinson's disease and parkinsonism in Italy (1969-1987)

artículo científico publicado el 1 de enero de 1992

Motor outcomes in patients with advanced Parkinson's disease treated with levodopa/carbidopa intestinal gel in Italy: an interim analysis from the GREENFIELD observational study

artículo científico publicado en 2016

Multicenter trial of L-Deprenyl in Parkinson disease

artículo científico publicado en 1986

Mutations in TMEM230 are not a common cause of Parkinson's disease.

artículo científico publicado en 2017

Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism

artículo científico publicado en 2003

New, selective catechol-O-methyltransferase inhibitors as therapeutic agents in Parkinson's disease

artículo científico publicado en 1999

Non-motor symptoms in atypical and secondary parkinsonism: the PRIAMO study

artículo científico publicado en 2009

Novel parkin mutations detected in patients with early-onset Parkinson's disease

artículo científico publicado en 2005

Origin of the mutations in the parkin gene in Europe: exon rearrangements are independent recurrent events, whereas point mutations may result from Founder effects

artículo científico publicado en 2001

PARK11 is not linked with Parkinson's disease in European families

article

PARK6 is a common cause of familial parkinsonism

artículo científico publicado en 2002

PARK6-linked parkinsonism occurs in several European families

artículo científico publicado en 2002

Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry

artículo científico publicado en 2010

Prevalence and clinical features of hedonistic homeostatic dysregulation in Parkinson's disease

artículo científico publicado en 2005

Psychosis associated to Parkinson's disease in the early stages: relevance of cognitive decline and depression

artículo científico publicado en 2011

Red flags for multiple system atrophy

artículo científico publicado en 2008

Relations between on-off phenomena and cognitive functions in Parkinson disease

artículo científico publicado en 1991

Reversible Pisa syndrome associated to subdural haematoma: case-report

artículo científico publicado en 2014

Risperidone for hallucinations in levodopa-treated Parkinson's disease patients

artículo científico publicado en 1994

Risperidone in levodopa induced dyskinesiae

artículo científico publicado en 1998

Risperidone in levodopa‐induced psychosis in advanced parkinson's disease: An open‐label, long‐term study ⬇️

artículo científico publicado el 1 de julio de 1997

Sad and happy facial emotion recognition impairment in progressive supranuclear palsy in comparison with Parkinson's disease

artículo científico publicado en 2012

TRH test and the continuous dopaminergic stimulation in complicated Parkinson's disease.

artículo científico publicado en 1992

The European Multiple System Atrophy-Study Group (EMSA-SG).

artículo científico publicado en 2005

The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson's disease and originates from a common ancestor

artículo científico publicado en 2005

The Ile93Met mutation in the ubiquitin carboxy-terminal-hydrolase-L1 gene is not observed in European cases with familial Parkinson's disease

artículo científico publicado en 1999

The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease

artículo científico publicado en 2009

The alpha-synuclein Ala53Thr mutation is not a common cause of familial Parkinson's disease: a study of 230 European cases. European Consortium on Genetic Susceptibility in Parkinson's Disease

artículo científico publicado en 1998

The natural history of multiple system atrophy: a prospective European cohort study

artículo científico publicado en 2013

The progression of non-motor symptoms in Parkinson's disease and their contribution to motor disability and quality of life

artículo científico publicado en 2012

Three parkin gene mutations in a sibship with autosomal recessive early onset parkinsonism

artículo científico publicado en 2001

[Cerebral phospholipids and Parkinson's disease: cross-over double-blind study versus placebo]

artículo científico publicado en 1981

Lista de obras de Giuseppe Meco

A case-control study on Alzheimer's disease and exposure to anesthesia

A cross-sectional multicenter study of cognitive and behavioural features in multiple system atrophy patients of the parkinsonian and cerebellar type

A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease

A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease.

A non-comparative assessment of tolerability and efficacy of duloxetine in the treatment of depressed patients with Parkinson's disease

A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease

ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease

An appraisal of the problem of dementia in Parkinson's disease.

Antidepressant use in treatment of psychosis with comorbid depression in Parkinson's disease

Apolipoprotein E4 is probably responsible for the chromosome 19 linkage peak for Parkinson's disease

Aripiprazole in L-dopa-induced dyskinesias: a one-year open-label pilot study.

Association between early-onset Parkinson's disease and mutations in the parkin gene

Attentional functions in multiple system atrophy and Parkinson's disease

Autosomal recessive early onset parkinsonism is linked to three loci: PARK2, PARK6, and PARK7

Belly dance syndrome due to spinal myoclonus

Biological effects of the PINK1 c.1366C>T mutation: implications in Parkinson disease pathogenesis.

Bladder symptoms assessed with overactive bladder questionnaire in Parkinson's disease

Buspirone in levodopa-induced dyskinesias

Chromosome 6-linked autosomal recessive early-onset Parkinsonism: linkage in European and Algerian families, extension of the clinical spectrum, and evidence of a small homozygous deletion in one family. The French Parkinson's Disease Genetics Study

Clinical subtypes in Parkinson's disease: the impact of MAPT haplotypes

Cognitive improvement during Tolcapone treatment in Parkinson's disease.

Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease

DAT gene polymorphisms (rs28363170, rs393795) and levodopa-induced dyskinesias in Parkinson's disease

Donepezil in the treatment of hallucinations and delusions in Parkinson's disease

Donepezil in the treatment of progressive supranuclear palsy

Early-onset parkinsonism associated with PINK1 mutations: frequency, genotypes, and phenotypes

Epidemiology of progressive supranuclear palsy. ESGAP Consortium. European Study Group on Atypical Parkinsonisms

Estimate of parkinsonism prevalence through drug prescription histories in the Province of Rome, Italy.

Evaluation of risk of Parkinson's disease in a cohort of licensed pesticide users.

Excessive daytime sleepiness in de novo and treated Parkinson's disease

Excessive daytime sleepiness in multiple system atrophy (SLEEMSA study).

Excessive daytime somnolence in Parkinson's disease. Follow-up after 1 year of treatment

Frontal assessment battery scores and non-motor symptoms in parkinsonian disorders

Frontal lobe dysfunction in essential tremor: a preliminary study

GIGYF2 mutations are not a frequent cause of familial Parkinson's disease

Genome-wide scan linkage analysis for Parkinson's disease: the European genetic study of Parkinson's disease

Hallucinations in Parkinson disease: neuropsychological study.

Health-related quality of life in multiple system atrophy

Hedonistic homeostatic dysregulation in Parkinson’s disease: a short screening questionnaire ⬇️

High prevalence of extrapyramidal signs and symptoms in a group of Italian dental technicians

How much phenotypic variation can be attributed to parkin genotype?

Hypothalamo-pituitary function and dopamine dependence in untreated parkinsonian patients

Increased expression of dopamine receptors on lymphocytes in Parkinson's disease

LRP10 genetic variants in familial Parkinson's disease and dementia with Lewy bodies: a genome-wide linkage and sequencing study

Levetiracetam in L-dopa-induced dyskinesia

Mirtazapine in L-dopa-induced dyskinesias

Mortality in a population-based cohort of patients treated with antiparkinsonian drugs.

Mortality rates for Parkinson's disease and parkinsonism in Italy (1969-1987)

Motor outcomes in patients with advanced Parkinson's disease treated with levodopa/carbidopa intestinal gel in Italy: an interim analysis from the GREENFIELD observational study

Multicenter trial of L-Deprenyl in Parkinson disease

Mutations in TMEM230 are not a common cause of Parkinson's disease.

Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism

New, selective catechol-O-methyltransferase inhibitors as therapeutic agents in Parkinson's disease

Non-motor symptoms in atypical and secondary parkinsonism: the PRIAMO study

Novel parkin mutations detected in patients with early-onset Parkinson's disease

Origin of the mutations in the parkin gene in Europe: exon rearrangements are independent recurrent events, whereas point mutations may result from Founder effects

PARK11 is not linked with Parkinson's disease in European families

PARK6 is a common cause of familial parkinsonism

PARK6-linked parkinsonism occurs in several European families

Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry

Prevalence and clinical features of hedonistic homeostatic dysregulation in Parkinson's disease

Psychosis associated to Parkinson's disease in the early stages: relevance of cognitive decline and depression

Red flags for multiple system atrophy

Relations between on-off phenomena and cognitive functions in Parkinson disease

Reversible Pisa syndrome associated to subdural haematoma: case-report

Risperidone for hallucinations in levodopa-treated Parkinson's disease patients

Risperidone in levodopa induced dyskinesiae

Risperidone in levodopa‐induced psychosis in advanced parkinson's disease: An open‐label, long‐term study ⬇️

Sad and happy facial emotion recognition impairment in progressive supranuclear palsy in comparison with Parkinson's disease

TRH test and the continuous dopaminergic stimulation in complicated Parkinson's disease.

The European Multiple System Atrophy-Study Group (EMSA-SG).

The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson's disease and originates from a common ancestor

The Ile93Met mutation in the ubiquitin carboxy-terminal-hydrolase-L1 gene is not observed in European cases with familial Parkinson's disease

The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease

The alpha-synuclein Ala53Thr mutation is not a common cause of familial Parkinson's disease: a study of 230 European cases. European Consortium on Genetic Susceptibility in Parkinson's Disease

The natural history of multiple system atrophy: a prospective European cohort study

The progression of non-motor symptoms in Parkinson's disease and their contribution to motor disability and quality of life

Three parkin gene mutations in a sibship with autosomal recessive early onset parkinsonism

[Cerebral phospholipids and Parkinson's disease: cross-over double-blind study versus placebo]